Product Information
MIBELAS 24 FE CHEWABLE TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3041 per EA under NDC 68180091173. Its NADAC has been published 330 times since Jun 10, 2020.
FDA first approved this application on May 24, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
MIBELAS 24 FE CHEWABLE TABLET
NORETHINDRONE ACETATE, ETHINYL ESTRADIOL AND FERROUS FUMARATEManufacturer
Lupin Pharmaceuticals Inc.NDC
68180091173
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA206287FDA Approved
5/24/2016
TE Code
AB
On Market Since
3/31/2020
Price Statistics
The NADAC for MIBELAS 24 FE CHEWABLE TABLET has been published 330 times since Jun 10, 2020, and over the history we have for it it has declined 90.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3041 per EA |
|---|---|
| All-time high | $3.0425 (Jun 10, 2020) |
| All-time low | $0.1310 (Oct 18, 2023) |
| 52-week high | $0.4407 |
| 52-week low | $0.2203 |
| Median price | $0.3342 |
| Average price | $0.5624 |
| Largest weekly change | +89.1% (Nov 22, 2023) |
| Weeks tracked | 330 |
| Tracking since | Jun 10, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the NORETHINDRONE ACETATE, ETHINYL ESTRADIOL AND FERROUS FUMARATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NORETHINDRONE ACETATE, ETHINYL ESTRADIOL AND FERROUS FUMARATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIBELAS 24 FE CHEWABLE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIBELAS 24 FE CHEWABLE TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3041 per EA (NDC 68180091173), effective Sep 30, 2026.
How has the price of MIBELAS 24 FE CHEWABLE TABLET changed over time?
Over the history we have for it, the NADAC for MIBELAS 24 FE CHEWABLE TABLET has declined 90.0%. It has been tracked across 330 weekly CMS publications since Jun 10, 2020.
What are the highest and lowest recorded NADAC prices for MIBELAS 24 FE CHEWABLE TABLET?
Since Jun 10, 2020, the NADAC for MIBELAS 24 FE CHEWABLE TABLET has ranged from a low of $0.1310 (Oct 18, 2023) to a high of $3.0425 (Jun 10, 2020), with a median of $0.3342 per EA.
Are there cheaper alternatives to MIBELAS 24 FE CHEWABLE TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MIBELAS 24 FE CHEWABLE TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MIBELAS 24 FE CHEWABLE TABLET?
MIBELAS 24 FE CHEWABLE TABLET (NDC 68180091173) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.